Preparation method of coenzyme Q10 capsule

Through dry extrusion preparation technology and water-soluble carrier dispersion system, the problems of Coenzyme Q10 being easily oxidized and low dissolution in wet granulation are solved, and its bioavailability and stability are improved, achieving efficient capsule preparation.

CN118948792AInactive Publication Date: 2024-11-15HEALTHYWAY BIO-TECH LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411069557.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-06
Publication Date
2024-11-15
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

Coenzyme Q10 is easily oxidized and has low dissolution in the existing wet granulation process, resulting in low bioavailability and drying treatment affects its stability.

Method used

Using dry extrusion preparation technology, Coenzyme Q10 is pressed with water-soluble pentosan modified β-cyclodextrin, and compact particles are formed by dry granulation, avoiding drying, improving water solubility and dispersion, and dispersing through carriers. The system enhances its solubility in water.

Benefits of technology

The bioavailability and stability of Coenzyme Q10 is improved, the dissolution is increased by 10%, and there is no precipitation, ensuring its high content and effectiveness in the capsule.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118948792A_ABST
    Figure CN118948792A_ABST
Patent Text Reader

Abstract

The invention discloses a preparation method of a coenzyme Q10 capsule. The coenzyme Q10 capsule is prepared by the following steps: step 1, weighing raw materials in parts by weight; step 2, sieving the coenzyme Q10 raw material powder; step 3, fully mixing the disintegrating agent, the water-soluble pentosan modified beta cyclodextrin and the coenzyme Q10 raw material powder, and putting the mixture into a dry type granulator for granulation; wherein the extrusion pressure is 7 kPa to 12 kPa, extruding into a sheet shape, and crushing into particles through vibration; step 4, mixing the crushed coenzyme Q10 into particles with lauryl sodium sulfate, calcium stearate and talcum powder at a high speed; and step 5, encapsulating the fully mixed raw materials to obtain the coenzyme Q10 capsule. The preparation method has the advantages that the coenzyme Q10 and the water-soluble pentosan modified beta cyclodextrin are pressed together by adopting a dry extrusion preparation technology, so that the water solubility of the coenzyme Q10 is greatly improved, the coenzyme Q10 is easier to absorb, no precipitate is generated after the coenzyme Q10 is dissolved, and the bioavailability of the coenzyme Q10 is improved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the field of capsule medicine preparation, and in particular to a preparation method of coenzyme Q10 capsules. Background Art

[0002] Coenzyme Q10 is an important endogenous vitamin in the human body, and the content of Coenzyme Q10 is relatively the highest in the heart. Part of the Coenzyme Q10 required by the body is provided by endogenous synthesis, and the rest is absorbed from food. When humans are 20 years old, the ability to synthesize Coenzyme Q10 autonomously reaches its peak and lasts until about 50 years old. It will decline year by year thereafter because the mitochondrial DNA material of the cells that store Coenzyme Q10 is damaged by oxygen free radicals, resulting in a decrease in the autonomous synthesis of Coenzyme Q10, resulting in a decrease in the metabolic function of human cells, especially heart cells. As an effective antioxidant and free radical scavenger, Coenzyme Q10 can inhibit the modification of free radicals on the microtubule system related to receptors and cell differentiation activity on immune cells, enhance the immune system, and delay aging.

[0003] However, since coenzyme Q10 is a fat-soluble quinone compound and a macromolecular substance that is difficult to dissolve in water, it is unstable to light, heat, and water, which limits the improvement of its bioavailability. On the other hand, coenzyme Q10 is an unstable substance that is easily oxidized and reduces its biological efficacy. Therefore, when making it into an orally available preparation, certain protective measures to prevent coenzyme Q10 from oxidation are necessary.

[0004] In the prior art, the preparation of coenzyme Q10 mostly adopts a wet granulation process, in which the coenzyme Q10 needs to be wetted and mixed with auxiliary materials for granulation. Since the process requires high-temperature drying, it has a great impact on the stability of coenzyme Q10, and the solubility is low, resulting in low bioavailability of coenzyme Q10. Summary of the invention

[0005] The technical problem to be solved by the present invention is how to reduce the decomposition of coenzyme Q10 during the granulation process. In view of the above technical problem to be solved, a method for preparing coenzyme Q10 capsules is now proposed.

[0006] To achieve the above object, the present invention provides the following technical solution: a method for preparing a coenzyme Q10 capsule, wherein the coenzyme Q10 capsule is prepared by the following steps:

[0007] Step 1: Weigh the following raw materials in proportion by weight:

[0008]

[0009]

[0010] Step 2, sieving the coenzyme Q10 raw material powder;

[0011] Step 3, the disintegrant, water-soluble pentosan-modified β-cyclodextrin and coenzyme Q10 raw material powder are fully mixed and put into a dry granulator for granulation; wherein the extrusion pressure is 7 kPa to 12 kPa, extruded into sheets, and broken into granules by shaking;

[0012] Step 4, mixing the coenzyme Q10 crushed into particles with sodium lauryl sulfate, calcium stearate and talc at high speed;

[0013] Step 5: The fully mixed raw materials are encapsulated to obtain coenzyme Q10 capsules.

[0014] Furthermore, the screening screen in step 2 is a 70-80 mesh screen.

[0015] Furthermore, the disintegrant is sodium carboxymethyl cellulose.

[0016] Furthermore, the extrusion temperature in step 3 is 15° C.-25° C., the extrusion relative humidity is 60%-65%, and the rotation speed of the tablet press is set to 35-65 rpm.

[0017] Furthermore, in the water-soluble pentosan-modified β-cyclodextrin in step 3, the weight ratio of the raw materials of water-soluble pentosan and β-cyclodextrin is 1:2.

[0018] Compared with the prior art, the present invention has the following beneficial effects:

[0019] The present invention adopts dry extrusion preparation technology and compresses coenzyme Q10 together with water-soluble pentosan-modified β-cyclodextrin, thereby greatly improving the water solubility of coenzyme Q10, making it easier to be absorbed, improving the solubility of coenzyme Q10, and no precipitation is generated when left to stand after dissolution, thereby improving the bioavailability of coenzyme Q10. BRIEF DESCRIPTION OF THE DRAWINGS

[0020] Figure 1 It is a schematic diagram of the method flow in the present invention; DETAILED DESCRIPTION

[0021] The following will be combined with the drawings in the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0022] See also Figure 1 The present specific embodiment discloses a method for preparing a coenzyme Q10 capsule, wherein the coenzyme Q10 capsule is prepared by the following steps:

[0023] Step 1: Weigh the following raw materials in proportion by weight:

[0024] Coenzyme Q10 raw powder 40 servings

[0025]

[0026] Preferably, sodium carboxymethyl cellulose is used as a disintegrant to increase the absorption rate of coenzyme Q10.

[0027] The weight ratio of the raw materials of water-soluble pentosan and β-cyclodextrin in the water-soluble pentosan-modified β-cyclodextrin in step 3 is 1:2. As a feasible technical means, water-soluble pentosan-β-cyclodextrin is prepared by dissolving β-cyclodextrin in an aqueous solution, heating it in a water bath at 35°C, and continuously adding water-soluble pentosan, stirring and dissolving it, then slowly heating to evaporate the water and drying it, and grinding it to obtain water-soluble pentosan-β-cyclodextrin powder. By dissolving, the water-soluble pentosan is filled into the gaps of β-cyclodextrin, thereby improving its water solubility.

[0028] Step 2: sieve the coenzyme Q10 raw material powder. Preferably, in this step, the sieve is a 70-80 mesh sieve.

[0029] Step 3, the disintegrant, water-soluble pentosan-modified β-cyclodextrin and coenzyme Q10 raw material powder are fully mixed and put into a dry granulator for granulation; wherein the extrusion pressure is 7 kPa to 12 kPa, extruded into sheets, and broken into granules by vibration; the extrusion temperature in step 3 is 15°C-25°C, the extrusion relative humidity is 60%-65%, and the speed of the tablet press is set to 35-65 rpm.

[0030] Step 4, mixing the coenzyme Q10 crushed into particles with sodium lauryl sulfate, calcium stearate and talc at high speed;

[0031] Step 5: The fully mixed raw materials are encapsulated to obtain coenzyme Q10 capsules.

[0032] The present invention adopts dry extrusion preparation technology and dry granulation to avoid the influence of drying treatment on coenzyme Q10, and obtains particles with compact structure by dry method under strong pressure. In addition, the particles have low air content, good fluidity and are easy to fill. The process of this method does not need to go through the process of granulation and drying, and the stability of coenzyme Q10 can be guaranteed. This external force can destroy the molecular cohesion between large particles, so that the large particles are squeezed and ground into nano-scale particles, and coenzyme Q10 and the carrier are combined with hydrogen bonds to form a solid dispersion, and the poorly soluble coenzyme Q10 forms a molecular dispersion system in the water-soluble carrier to improve the solubility of coenzyme Q10 in the aqueous medium.

[0033] Coenzyme Q10 is compressed together with water-soluble pentosan-modified β-cyclodextrin, thereby greatly improving the water solubility of coenzyme Q10, making it easier to absorb, improving the solubility of coenzyme Q10, and no precipitation is produced after dissolution, thereby improving the bioavailability of coenzyme Q10. Coenzyme Q10 particles are prepared using a solid dispersion system of a water-soluble carrier to break the strong molecular forces and achieve physical mixing of substances, thereby improving the solubility of coenzyme Q10 in aqueous media. Coenzyme Q10 is combined with a carrier to form a molecular structure that exists in a solid dispersion carrier, transforming coenzyme Q10 from a crystalline state to an amorphous state.

[0034] The dry granulation process mixes coenzyme Q10 and auxiliary material powders evenly, compresses them into tablets, and then crushes and granulates them into the required size. This method relies on compression force to generate binding force between molecules. This preparation method integrates the microcrystal and dispersion processes of poorly soluble coenzyme Q10 with granulation. Preferably, during the period, the pressure, gap, pressure wheel speed and other data related to quality are controlled and measured online to meet the requirements through repeated small tests. Different types of rotors and screens can be selected according to the characteristics of each batch of materials to achieve the optimal particle size distribution effect, highly disperse the poorly soluble coenzyme Q10 in suitable auxiliary materials, change the surface properties, and make particles with different characteristics stick together during the compaction process, thereby improving the solubility of poorly soluble coenzyme Q10.

[0035] The coenzyme Q10 capsules prepared by the above method and the coenzyme Q10 capsules prepared by conventional wet extrusion were tested as a control group. It was found that the coenzyme Q10 capsules prepared by the method contained more than 8.3g of coenzyme Q10 per 100g of capsules, while the coenzyme Q10 capsules prepared by wet extrusion contained only 6.5-7.5g of coenzyme Q10 per 100g of capsules. The solubility of coenzyme Q10 prepared by the method was increased by 10% compared with the original process.

[0036] Example 1

[0037] Coenzyme Q10 capsules were prepared according to the above method, and the extrusion pressure in step 3 was 7 kPa, the extrusion temperature was 15° C., the extrusion relative humidity was set to 60%, and the speed of the tablet press was set to 35 rpm.

[0038] Example 2

[0039] Coenzyme Q10 capsules were prepared according to the above method, and the extrusion pressure in step 3 was set to 9.5 kPa, the extrusion temperature was set to 20° C., the extrusion relative humidity was set to 62.5%, and the speed of the tablet press was set to 50 rpm.

[0040] Example 3

[0041] Coenzyme Q10 capsules were prepared according to the above method, and the extrusion pressure in step 3 was 12 kPa, extruded into sheets, and broken into particles by shaking; the extrusion temperature was 25° C., the extrusion relative humidity was 65%, and the speed of the tablet press was set to 65 rpm.

[0042] Controlled trials:

[0043] The capsules prepared in Example 2 and the coenzyme Q10 purchased from Shenmou Biological on the market were used as control group tests. Five groups of capsules in Example 2 were taken and marked with No. 2001-2005 respectively. The coenzyme Q10 purchased from the market was used as control 1, and dissolution tests were performed respectively.

[0044]

[0045] The embodiments of the present invention are described in detail above with reference to the accompanying drawings, but the present invention is not limited to the described embodiments. For those skilled in the art, various changes, modifications, substitutions and variations of these embodiments are made without departing from the principles and spirit of the present invention, and still fall within the scope of protection of the present invention.

Claims

1. A method for preparing coenzyme Q10 capsules, characterized in that: Coenzyme Q10 capsules are prepared by the following steps: Step 1: Weigh the following raw materials in proportion by weight: Step 2, sieving the coenzyme Q10 raw material powder; Step 3, the disintegrant, water-soluble pentosan-modified β-cyclodextrin and coenzyme Q10 raw material powder are fully mixed and put into a dry granulator for granulation; wherein the extrusion pressure is 7 kPa to 12 kPa, extruded into sheets, and broken into granules by shaking; Step 4, mixing the coenzyme Q10 crushed into particles with sodium lauryl sulfate, calcium stearate and talc at high speed; Step 5: The fully mixed raw materials are encapsulated to obtain coenzyme Q10 capsules.

2. The method for preparing a coenzyme Q10 capsule according to claim 1, characterized in that: The sieving screen in step 2 is a 70-80 mesh screen.

3. The method for preparing a coenzyme Q10 capsule according to claim 1, characterized in that: The disintegrant is sodium carboxymethyl cellulose.

4. The method for preparing a coenzyme Q10 capsule according to claim 1, characterized in that: The extrusion temperature in step 3 is 15° C.-25° C., the extrusion relative humidity is 60%-65%, and the rotation speed of the tablet press is set to 35-65 rpm.

5. The method for preparing a coenzyme Q10 capsule according to claim 1, characterized in that: The weight ratio of the raw materials of water-soluble pentosan and β-cyclodextrin in the water-soluble pentosan-modified β-cyclodextrin in step 3 is 1:2.